| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/01/2009 | CA2213343C Chimeric adenoviral fiber protein and methods of using same |
| 08/27/2009 | WO2009105557A1 Use of therapeutic peptides for the treatment and prevention of cancer |
| 08/27/2009 | WO2009105269A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof |
| 08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
| 08/27/2009 | WO2009103826A1 System for producing multimeric peptides and proteins and use thereof |
| 08/27/2009 | WO2009041830A9 Cell-permeabilising peptides and polypeptides for microbial cells |
| 08/27/2009 | WO2007092934A8 Methods and compositions for modifying plant biosynthetic pathways |
| 08/27/2009 | US20090217391 T1r3 a novel taste receptor |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215691 NOGO Receptor Antagonists |
| 08/27/2009 | US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection |
| 08/27/2009 | US20090214576 Tyrosine kinase inhibitor compositions and methods for manufacturing and using them in the treatment of disease |
| 08/27/2009 | US20090214574 Anti-cd16 binding molecules |
| 08/27/2009 | CA2715324A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 08/27/2009 | CA2714939A1 Use of therapeutic peptides for the treatment and prevention of cancer |
| 08/26/2009 | EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 08/26/2009 | EP2093287A1 Igg-binding peptide |
| 08/26/2009 | EP2092343A1 Detection conjugate |
| 08/26/2009 | EP2091972A1 Multi-modal cancer therapy using viral hitch-hiking |
| 08/26/2009 | EP1282636B1 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 08/26/2009 | CN101517077A Multi-gene expression vehicle |
| 08/26/2009 | CN101516915A Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 08/26/2009 | CN101514232A RANKL-Fc fusion protein, preparation method and application thereof |
| 08/26/2009 | CN101514231A Fusion protein for resisting formation of thrombus targetedly and preparation method and application thereof |
| 08/26/2009 | CN100531794C Compositions and methods for modifying toxic effects of protein compounds |
| 08/25/2009 | US7579437 Polypeptides and methods for making the same |
| 08/25/2009 | US7579168 Human Dickkopf-related nucleic acid molecules |
| 08/25/2009 | CA2395539C Soluble interleukin-20 receptor |
| 08/25/2009 | CA2088889C Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy |
| 08/20/2009 | WO2009102782A2 Increasing efficiency of nucleic acid delivery in vivo using targeting conjugates |
| 08/20/2009 | WO2009102357A2 Hiv-1 envelope glycoprotein oligomer and methods of use |
| 08/20/2009 | WO2009101737A1 Protein expression vector tagged with peptide having methionine residue |
| 08/20/2009 | WO2009101672A1 Fused protein containing insulin precursor of overexpression and secretion type, dna encoding the same and method of producing insulin |
| 08/20/2009 | WO2009101403A1 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus |
| 08/20/2009 | WO2009079242A3 Aglycosylated immunoglobulin mutants |
| 08/20/2009 | US20090209006 Taci-immunoglobulin fusion proteins |
| 08/20/2009 | US20090208970 Probe for detection and quantification of inositol-1,4,5-trisphosphate and a method for detecting and quantifying inositol-1,4,5-trisphosphate using the same |
| 08/20/2009 | US20090208504 Polypeptides involved in immune response |
| 08/20/2009 | CA2715177A1 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus |
| 08/20/2009 | CA2705373A1 Hiv-1 envelope glycoprotein oligomer and methods of use |
| 08/19/2009 | EP2090591A2 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 08/19/2009 | EP2090589A1 Albumin-fused Kunitz domain peptides |
| 08/19/2009 | EP1280566B1 Growth factor modified protein matrices for tissue engineering |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | EP1187918B9 Tek antagonists |
| 08/19/2009 | CN101511873A Fusion polypeptide for inhibiting neurotransmitter secretion and method for delivering it |
| 08/19/2009 | CN101511872A Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
| 08/19/2009 | CN101511868A Exendin fusion proteins |
| 08/19/2009 | CN101509007A Synthesis of LfcinB15-Mag12 encoding gene and expression method in colon bacillus |
| 08/19/2009 | CN100529076C Mammalian cytokines, related reagents and methods |
| 08/19/2009 | CN100528899C Fusion protein and nucleic acid containing peptide carrier and epidermal growth factor and its uses |
| 08/19/2009 | CN100528896C Chimeric antigen for preventing, diagnozing and treating respiratory syncytial virus infection and its antibody |
| 08/18/2009 | US7576193 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 08/18/2009 | US7575923 CD19xCD3 specific polypeptides and uses thereof |
| 08/18/2009 | US7575898 Comprises nucleotide sequences coding zein and therapeutic proteins for expression in plants; bioreactors; gene therapy |
| 08/18/2009 | US7575879 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; bradycardial agents; identification and preparation of vascular endothelial growth factor-E (VEGF-E), a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1 |
| 08/18/2009 | US7575763 Membrane scaffold proteins and tethered membrane proteins |
| 08/18/2009 | CA2105552C Soluble ligands for cd40 |
| 08/18/2009 | CA2054798C Hcv-specific peptides, agents therefor and the use thereof |
| 08/13/2009 | WO2009100127A2 Isolated brca1 peptides and method of use |
| 08/13/2009 | WO2009099961A2 Engineered antibody constant domain molecules |
| 08/13/2009 | WO2009099777A2 Chimeric hiv fusion proteins as vaccines |
| 08/13/2009 | WO2009016515A3 Compositions comprising pneumococcal antigens |
| 08/13/2009 | WO2008071081A8 Preparation of low bleeding anticoagulant fusion protein and its use |
| 08/13/2009 | WO2007108749A8 Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents |
| 08/13/2009 | US20090203842 Macromolecular Conjugates And Processes For Preparing The Same |
| 08/13/2009 | US20090203627 Specific binding sites in collagen for integrins and use thereof |
| 08/13/2009 | US20090203026 Methods and compositions for targeting secretory lysosomes |
| 08/13/2009 | US20090202580 Method for the preparation of specific antibodies against saccharidic antigens |
| 08/13/2009 | US20090202494 Combined use of glp-1 agonists and gastrin for regulating blood glucose levels |
| 08/13/2009 | US20090202487 Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology |
| 08/13/2009 | CA2713281A1 Engineered antibody constant domain molecules |
| 08/12/2009 | EP2088197A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 08/12/2009 | EP1896588B1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |
| 08/12/2009 | EP1675579B1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 08/12/2009 | EP1550672B1 Chimeric antagonist anth1 |
| 08/12/2009 | EP1465912B9 Chimeric tnf ligands |
| 08/12/2009 | EP1385882B9 Peptides and related molecules that bind to tall-1 |
| 08/12/2009 | EP1299414B1 Fluorescent proteins |
| 08/12/2009 | EP1259608B1 Modified fluorescent proteins |
| 08/12/2009 | EP1137941B1 Protein scaffolds for antibody mimics and other binding proteins |
| 08/12/2009 | CN101503475A Fusion protein of anthrax lethal factor domain (LFn) and anthrax edema factor domain (EFn) and use thereof |
| 08/12/2009 | CN101503474A Human vascular endothelial cell growth inhibition factor jogged polypeptide, preparation thereof and use in targeted antineoplastic activity |
| 08/11/2009 | US7572899 Compositions and methods for increasing bone mineralization |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572437 Long acting human interferon analogs |
| 08/11/2009 | CA2271248C Use of a notch ligand in immunotherapy |
| 08/11/2009 | CA2241572C Apo-2 ligand |
| 08/06/2009 | WO2009097568A1 Dna repair polypeptides and methods of delivery and use |
| 08/06/2009 | WO2009096112A1 Tag peptide and use thereof |
| 08/06/2009 | WO2009095500A1 Inhibitors of lentiviral replication |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | CA2854933A1 Methods and compositions using soluble klotho proteins |
| 08/06/2009 | CA2712900A1 Dna repair polypeptides and methods of delivery and use |
| 08/05/2009 | EP2085475A1 Method for production of cell strain capable of tetracycline-induced gene expression or cell strain having conditional gene knockout, and use of the cell strains |
| 08/05/2009 | EP2085098A2 Peptide chimeric molecules having antiviral properties against viruses of the flaviviridae family |
| 08/05/2009 | EP1624884A4 Somatostatin vectors |
| 08/05/2009 | CN101497666A Double specificity oligopeptide-cefuroxime sodium strengthened fusion protein Ec-LDP-Hr-AE |
| 08/05/2009 | CN100523198C Method for detection of leptin receptor ligands |